# FDA Inspection 1102088 - Biomat USA, Inc. - September 11, 2019

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/0a2357a2-2acd-4ea1-aae6-6b7cb8cf5e90
Source feed: FDA_Inspections

> FDA Inspection 1102088 for Biomat USA, Inc. on September 11, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102088
- Company Name: Biomat USA, Inc.
- Inspection Date: 2019-09-11
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1259453 - 2024-12-19](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/8d866106-155d-4250-8878-b69f7e785e8c)
- [FDA Inspection 1259453 - 2024-12-19](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/7bbb86ac-22c6-4b42-bd97-294b73d74d98)
- [FDA Inspection 989350 - 2016-10-17](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/0bab99fe-1f9d-4b24-becd-3fc16b08c2c7)
- [FDA Inspection 935336 - 2015-07-17](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/78c1af8c-ca13-4b2c-924f-d0a02070c50c)
- [FDA Inspection 847837 - 2013-09-11](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/a66deadd-9c4e-43d0-a533-93bfc5dac3c8)

Company: https://www.keypedia.com/companies/biomat-usa-inc/24706029-940f-43a6-beaa-89019324fb24

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d